ChemicalBook >> CAS DataBase List >>ONO 3708

ONO 3708

CAS No.
102191-05-9
Chemical Name:
ONO 3708
Synonyms
ONO 3708;(Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentylhydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid;(Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentyl(hydroxy)acetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2α-yl]-5-heptenoic acid;5-Heptenoic acid, 7-[(1S,2S,3S,5R)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2-yl]-, (5Z)-
CBNumber:
CB41327045
Molecular Formula:
C23H37NO4
Molecular Weight:
391.54
MDL Number:
MFCD01753215
MOL File:
102191-05-9.mol
Last updated:2025-04-18 09:52:15

ONO 3708 Properties

Boiling point 598.7±33.0 °C(Predicted)
Density 1.14±0.1 g/cm3(Predicted)
pka 4.76±0.10(Predicted)
FDA UNII 88SI3G560K

ONO 3708 Chemical Properties, Uses, Production

Uses

ONO 3708 is a TXA2/PGH2 receptor antagonist that can inhibit the binding properties of U46619 in unactivated intact human platelets, with an IC50 value of 38 nM[1].

References

[1] Kattelman EJ, et al. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). Thromb Res. 1986 Feb 15;41(4):471-81. DOI:10.1016/0049-3848(86)91692-0

ONO 3708 Preparation Products And Raw materials

Raw materials

Preparation Products

ONO 3708 Suppliers

Global Suppliers ( 4)
Supplier Tel Email Country ProdList Advantage
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 9920 65
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58

102191-05-9 (ONO 3708) Related Search:

ONO 3708 (Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentyl(hydroxy)acetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2α-yl]-5-heptenoic acid (Z)-7-[(1S,5R)-3β-[[(R)-Cyclopentylhydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid 5-Heptenoic acid, 7-[(1S,2S,3S,5R)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2-yl]-, (5Z)- 102191-05-9